A Randomized Phase 3 Study, Sinus-52, Evaluating the Efficacy and Safety of Dupilumab in Patients with Severe Chronic Rhinosinusitis with Nasal Polyps

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 2019-02, Vol.143 (2), p.AB433-AB433
Main Authors: Bachert, Claus, Desrosiers, Martin, Mullol, Joaquim, Hellings, Peter W., Cervin, Anders, Sher, Lawrence, Bosso, John V., Lee, Stella E., Maspero, Jorge F., Fujieda, Shigeharu, Matsune, Shoji, Lu, Xin, Fan, Chunpeng, Draikiwicz, Steven, Amin, Nikhil, Kamat, Siddhesh, Khan, Asif, Pirozzi, Gianluca, Graham, Neil M.H., Ruddy, Marcella, Staudinger, Heribert, Mannent, Leda P.
Format: Article
Language:English
Subjects:
Asthma
Endoscopy
Immunotherapy
Monoclonal antibodies
Patients
Polyps
Rhinitis
Rhinosinusitis
Sinusitis
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2018.12.980